Skip to main content
    C

    Clearside Biomedical Inc (CLSD)

    Official site

    BIOTECHNOLOGY

    $0.41
    +0.00 (+0.00%)

    Last updated: Oct 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    44%(16/36)
    Avg Surprise
    -74.86%
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 18
    		$-1.14$-0.07-1598.96%Miss-1040.0%
    Jun 25
    Reported Aug 8
    		$-0.87$-0.10-745.48%Miss-770.0%
    Mar 25
    Reported May 14
    		$-0.11$-0.14+21.43%Beat+26.7%
    Dec 24
    Reported Mar 27
    		$-0.10$-0.10+3.19%Beat-25.0%
    Sep 24
    Reported Nov 12
    		$-0.10$-0.12+16.67%Beat+33.3%
    Jun 24
    Reported Aug 12
    		$-0.10$-0.13+23.08%Beat+33.3%
    Mar 24
    Reported May 9
    		$-0.15$-0.14-7.14%Miss+0.0%
    Dec 23
    Reported Mar 12
    		$-0.08$-0.09+11.11%Beat+50.0%
    Sep 23
    Reported Nov 13
    		$-0.15$-0.15+0.00%Beat-15.4%
    Jun 23
    Reported Aug 14
    		$-0.15$-0.14-7.14%Miss-15.4%
    Mar 23
    Reported May 11
    		$-0.15$-0.14-7.14%Miss-15.4%
    Dec 22
    Reported Mar 9
    		$-0.16$-0.13-23.08%Miss-151.6%
    Sep 22
    Reported Nov 9
    		$-0.13$-0.03-333.33%Miss-62.5%
    Jun 22
    Reported Aug 9
    		$-0.13$-0.13+0.00%Beat-18.2%
    Mar 22
    Reported May 11
    		$-0.13$-0.08-62.50%Miss+0.0%
    Dec 21
    Reported Mar 10
    		$0.31$0.16+93.75%Beat+321.4%
    Sep 21
    Reported Nov 10
    		$-0.08$-0.08+0.00%Beat-60.0%
    Jun 21
    Reported Aug 10
    		$-0.11$-0.13+15.38%Beat+15.4%
    Mar 21
    Reported May 17
    		$-0.13$-0.10-30.00%Miss-85.7%
    Dec 20
    Reported Mar 10
    		$-0.14$-0.11-27.27%Miss-100.0%
    Sep 20
    Reported Nov 10
    		$-0.05N/A+58.33%Beat+70.6%
    Jun 20
    Reported Aug 10
    		$-0.13$-0.12-8.33%Miss+40.9%
    Mar 20
    Reported May 8
    		$-0.07$-0.11+36.36%Beat+84.4%
    Dec 19
    Reported Mar 11
    		$-0.07$-0.07+0.00%Beat+89.7%
    Sep 19
    Reported Nov 6
    		$-0.17$-0.16-6.25%Miss+77.3%
    Jun 19
    Reported Aug 7
    		$-0.22$-0.39+43.59%Beat+66.2%
    Mar 19
    Reported May 8
    		$-0.45$-0.40-12.50%Miss+27.4%
    Dec 18
    Reported Mar 12
    		$-0.68$-0.57-19.30%Miss-4.6%
    Sep 18
    Reported Nov 8
    		$-0.75$-0.63-19.05%Miss-4.2%
    Jun 18
    Reported Aug 8
    		$-0.65$-0.58-12.07%Miss-20.4%
    Mar 18
    Reported May 9
    		$-0.62$-0.58-6.90%Miss-51.2%
    Dec 17
    Reported Mar 14
    		$-0.65$-0.70+7.14%Beat-44.4%
    Sep 17
    Reported Nov 8
    		$-0.72$-0.55-30.91%Miss-
    Jun 17
    Reported Aug 9
    		$-0.54$-0.41-31.71%Miss-
    Mar 17
    Reported May 10
    		$-0.41$-0.43+4.65%Beat-
    Dec 16
    Reported Mar 14
    		$-0.45$-0.32-40.63%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROIC31.02%
    Financial Health
    Debt/Equity-0.01xInterest CoverageN/A
    Current Ratio2.98xQuick Ratio2.98x
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.41
    SMA 20$0.41
    SMA 50$0.41
    SMA 200$0.84
    EMA 10$0.41
    EMA 20$0.41
    EMA 50$0.41
    EMA 200$1.68

    MACD

    Line: N/ASignal: N/AHist: N/A

    ADX

    ADX: 72.2+DI: 6.7-DI: 41.7

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down100.0
    PSAR$0.41

    Bollinger Bands

    Upper Band$0.41
    Lower Band$0.41
    %B Position0%(Lower)
    Band Width0.50

    RSI (14-Day)

    Oversold
    16.1

    Momentum Oscillators

    Stoch %KN/A
    Stoch %DN/A
    Williams %RN/A
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)N/A
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)N/A(0.0%)
    StdDev (20d)N/A
    Hist VolN/A

    Volume Flow

    VWAP$0.41
    OBV187.2M
    AD Line39.7B
    CMF (20d)N/A

    Volume Metrics

    Avg Vol (20d)N/A
    Vol RatioN/A
    VWMA (20d)N/A

    Pivot Points

    R3$0.41
    R2$0.41
    R1$0.41
    Pivot Point$0.41
    S1$0.41
    S2$0.41
    S3$0.41

    Advanced Oscillators

    TSI-69.89
    Ultimate OscN/A
    KSTN/A

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$201,000$492,000$2.33M$306,000$1.04M$90,000$230,000$6.34M$859,000$1.02M$4,000$330,000
    Cost of Revenue$0$84,000$248,000$149,000$0$44,000$28,000$20,000$142,000$213,000$15,000$204,000
    Gross Profit$201,000$408,000$2.08M$157,000$1.04M$90,000$202,000$6.33M$717,000$805,000$4,000$126,000
    Operating ExpensesN/A$3.98M$7.29M$7.31M$6.97M$7.68M$8.41M$9.24M$7.77M$8.07M$7.61M$8.20M
    R&D$0$1.58M$4.46M$4.24M$4.13M$4.60M$5.59M$6.29M$5.13M$4.95M$4.45M$5.03M
    SG&A$0$2.48M$2.82M$3.06M$2.84M$3.08M$2.82M$2.95M$2.64M$3.13M$3.16M$3.17M
    Operating Income$-7,040,000$-3,568,000$-5,205,000$-7,149,000$-5,934,000$-7,590,000$-8,209,000$-2,915,000$-7,054,000$-7,270,000$-7,605,000$-8,070,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$2.76M$2.67M$2.58M$2.46M$2.34M$2.40M$2.28M$2.62M$2.29M$2.17M$2.04M
    Income Before Tax$0$-4,495,000$-7,508,000$-7,306,000$-7,688,000$-7,594,000$-11,763,000$-4,832,000$-9,267,000$-9,106,000$-9,280,000$-9,663,000
    Income Tax Expense$0$0$715,000$0$0$0$1$-6,578,000$-16,000$2.75M$3.84M$-1,074,330
    Net Income$-5,972,000$-4,495,000$-8,223,000$-7,306,000$-7,688,000$-7,594,000$-11,763,000$-4,832,000$-9,267,000$-9,106,000$-9,280,000$-8,588,670
    EBITDA$-3,318,000$-3,568,000$-4,750,000$-4,648,000$-5,156,000$-5,210,000$-9,332,000$-2,535,000$-6,629,000$-6,796,000$-7,098,000$-7,599,000
    EBIT$-3,402,000$-3,652,000$-4,835,000$-4,727,000$-5,231,000$-5,254,000$-9,360,000$-2,555,000$-6,645,000$-6,812,000$-7,113,000$-7,621,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CLSD

    News

    No news available

    Company news will appear here when available

    CLSD Valuation and Fair Value

    P/B
    -0.0x
    See GNG's fair value

    CLSD Profitability: Margins, ROIC and FCF

    Gross margin
    85.6%
    ROIC
    31.0%

    CLSD Competitors

    CompanyTicker
    Qualigen Therapeutics IncQLGN
    BioRestorative Therapies IncBRTX
    Im Cannabis CorpIMCC
    Beyond Air IncXAIR
    Nuwellis IncNUWE
    NewGenIvf Group Limited Class A Ordinary SharesNIVF
    Scisparc LtdSPRC
    Purple BiotechPPBT

    Sector: Healthcare

    CLSD Bull Case vs Bear Case

    Bull case

    • CLSD earns a 31.0% return on invested capital.

    CLSD Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -284.5%

    Frequently Asked Questions About CLSD

    Does CLSD pay dividends?

    Clearside Biomedical Inc (CLSD) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In